We caught up with Md Ekramul Karim, a Ph.D. candidate at the University of Houston, who is one of the newest Junior Reviewers with Letters in Applied Microbiology.
A new study indicates greater wax moth larvae show great potential as a robust and ethically acceptable in vivo model for studying pathogenic bacteria.
Researchers have reported encouraging results from an early clinical trial that tested a new dual vaccine against Lassa fever and rabies. The study found that the vaccine was safe and induced immune responses against both viruses. There are currently no vaccines against Lassa fever on the market.
A new agricultural project will help reduce the use of synthetic nitrogen fertilizer through the design of corn plants that better use nitrogen already in the soil.
Astronauts on long space missions may one day use plants to produce fresh stocks of medicines on demand. Researchers developed a simple method to grow and repeatedly harvest plant virus-based pharmaceuticals from plants under space-like conditions, without destroying the plants or generating large amounts of waste.
Researchers say a newly proposed three-step “detour” pathway for making dolichol may be more universal than scientists realized. Experiments in yeast suggest eukaryotes may rely on overlapping biochemical pathways, including the evolutionarily conserved “detour” and evidence of a possible “backup route,” to produce a molecule essential to life.
Researchers have reported encouraging results from an early clinical trial that tested a new dual vaccine against Lassa fever and rabies. The study found that the vaccine was safe and induced immune responses against both viruses. There are currently no vaccines against Lassa fever on the market.
Astronauts on long space missions may one day use plants to produce fresh stocks of medicines on demand. Researchers developed a simple method to grow and repeatedly harvest plant virus-based pharmaceuticals from plants under space-like conditions, without destroying the plants or generating large amounts of waste.
Researchers say a newly proposed three-step “detour” pathway for making dolichol may be more universal than scientists realized. Experiments in yeast suggest eukaryotes may rely on overlapping biochemical pathways, including the evolutionarily conserved “detour” and evidence of a possible “backup route,” to produce a molecule essential to life.
Andelyn Biosciences has announced the launch of its LVV Curator® Platform, a standardized lentiviral vector (LVV) manufacturing solution built on the same proven modular approach that supports clinical and commercial adeno-associated virus (AAV) programs.
Modular Clean Air (MCA) is now wholly owned by Total Clean Air (TCA), marking the next phase in its development following its successful launch as a joint venture in 2025.
Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG.
A new study indicates greater wax moth larvae show great potential as a robust and ethically acceptable in vivo model for studying pathogenic bacteria.
A new agricultural project will help reduce the use of synthetic nitrogen fertilizer through the design of corn plants that better use nitrogen already in the soil.
Astronauts on long space missions may one day use plants to produce fresh stocks of medicines on demand. Researchers developed a simple method to grow and repeatedly harvest plant virus-based pharmaceuticals from plants under space-like conditions, without destroying the plants or generating large amounts of waste.
We caught up with Md Ekramul Karim, a Ph.D. candidate at the University of Houston, who is one of the newest Junior Reviewers with Letters in Applied Microbiology.
Conservation stakeholders gathered to celebrate the official opening of the Laboratory in Northern Kenya (LiNK), an all-new veterinary diagnostic lab designed to fill a critical need for accessible diagnostic infrastructure in the remote region.
Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.